Return
Lipid-based nanocarriers for antiviral drug delivery: A review of the advances, manufacturing technologies, therapeutic mechanisms, and clinical applications
H
P
K
R
DOI:10.1016/j.chemphyslip.2026.105574.png)
Abstract
En 中文
• Lipid nanocarriers (LNCs) demonstrate improved antiviral efficacy. • LNCs offer high payload capacity, physicochemical tunability and enhanced cellular uptake in antiviral therapeutics. • LNCs encapsulate a wide range of antiviral agents and has expanded the scope of antiviral therapies.
Journal
IF:
2.8
Papers:
3.3K
Citations:
4.7K
